Reversible transition from a hypertrophic to a dilated cardiomyopathy

被引:3
作者
Spillmann, Frank [1 ]
Kuehl, Uwe [1 ]
Van Linthout, Sophie [2 ,3 ]
Dominguez, Fernando [4 ]
Escher, Felicitas [1 ,5 ]
Schultheiss, Heinz-Peter [5 ]
Pieske, Burkert [1 ,3 ,6 ]
Tschoepe, Carsten [1 ,2 ,3 ]
机构
[1] Charite, Campus Virchow Klinikum, Dept Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Campus Virchow Klinikum, D-13353 Berlin, Germany
[3] Charite, Deutsch Zentrum Herz Kreislaufforsch DZHK Standor, Berlin, Germany
[4] Hosp Univ Puerta de Hierro, Dept Cardiol, Madrid, Spain
[5] IKDT Inst Kardiale Diagnost & Therapie GmbH, Berlin, Germany
[6] Deutsch Herzzentrum Berlin DHZB, Dept Cardiol, Berlin, Germany
关键词
Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Transition of cardiomyopathy; PHOSPHORYLASE-KINASE DEFICIENCY; ACTIVATED-PROTEIN-KINASE; GLYCOGENOSIS; PRKAG2; GAMMA-2-SUBUNIT; MYOCARDITIS; PREVALENCE; MUTATION; ADULTS; HEART;
D O I
10.1002/ehf2.12072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the case of a 17-year-old female patient with known hypertrophic cardiomyopathy and a Wolff-Parkinson-White syndrome. She came to our department for further evaluation of a new diagnosed dilated cardiomyopathy characterized by an enlargement of the left ventricle and a fall in ejection fraction. Clinically, she complained about atypical chest pain, arrhythmic episodes with presyncopal events, and dyspnea (NYHA III) during the last 6months. Non-invasive and invasive examinations including magnetic resonance imaging, electrophysiological examinations, and angiography did not lead to a conclusive diagnosis. Therefore, endomyocardial biopsies (EMBs) were taken to investigate whether a specific myocardial disease caused the impairment of the left ventricular function. EMB analysis resulted in the diagnosis of a virus-negative, active myocarditis. Based on this diagnosis, an immunosuppressive treatment with prednisolone and azathioprine was started, which led to an improvement of cardiac function and symptoms within 3months after initiating therapy. In conclusion, we show that external stress triggered by myocarditis can induce a reversible transition from a hypertrophic cardiomyopathy to a dilated cardiomyopathy phenotype. This case strongly underlines the need for a thorough and invasive examination of heart failure of unknown causes, including EMB investigations as recommend by the actual ESC position statement.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 17 条
[1]   Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the γ2-subunit of AMP-Activated protein kinase [J].
Akman, Hasan O. ;
Sampayo, James N. ;
Ross, Fiona A. ;
Scott, John W. ;
Wilson, Gregory ;
Benson, Lee ;
Bruno, Claudio ;
Shanske, Sara ;
Hardie, D. Grahame ;
Dimauro, Salvatore .
PEDIATRIC RESEARCH, 2007, 62 (04) :499-504
[2]   Glycogen storage diseases presenting as hypertrophic cardiomyopathy [J].
Arad, M ;
Maron, BJ ;
Gorham, JM ;
Johnson, WH ;
Saul, JP ;
Perez-Atayde, AR ;
Spirito, P ;
Wright, GB ;
Kanter, RJ ;
Seidman, CE ;
Seidman, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :362-372
[3]   Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the γ2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency [J].
Burwinkel, B ;
Scott, JW ;
Bührer, C ;
van Landeghem, FKH ;
Cox, GF ;
Wilson, CJ ;
Hardie, DG ;
Kilimann, MW .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (06) :1034-1049
[4]  
CHERRY JM, 1986, CLIN INVEST MED, V9, pB31
[5]   Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias [J].
Chimenti, C ;
Calabrese, F ;
Thiene, G ;
Pieroni, M ;
Maseri, A ;
Frustaci, A .
CIRCULATION, 2001, 104 (02) :168-173
[6]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[7]   Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration [J].
Frustaci, Andrea ;
Verardo, Romina ;
Caldarulo, Marina ;
Acconcia, Maria Cristina ;
Russo, Matteo A. ;
Chimenti, Cristina .
EUROPEAN HEART JOURNAL, 2007, 28 (06) :733-740
[8]   Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study [J].
Frustaci, Andrea ;
Russo, Matteo A. ;
Chimenti, Cristina .
EUROPEAN HEART JOURNAL, 2009, 30 (16) :1995-2002
[9]   Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome [J].
Gollob, MH .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :228-231
[10]   Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy [J].
Harris, Kevin M. ;
Spirito, Paolo ;
Maron, Martin S. ;
Zenovich, Andrey G. ;
Formisano, Francesco ;
Lesser, John R. ;
Mackey-Bojack, Shannon ;
Manning, Warren J. ;
Udelson, James E. ;
Maron, Barry J. .
CIRCULATION, 2006, 114 (03) :216-225